Médecins Sans Frontières

MSF and Stop TB Partnership urge further action to address TB crisis at BRICS health meeting

Geneva, 16 December 2016

Read More →

MSF urges the Global Fund to freeze implementation of transition plans

Médecins Sans Frontières (MSF) expressed concerns about the Global Fund’s policies on allocation, co-financing, and transition.

Read More →

Tajikistan: Stories from MSF's paediatric TB projects

Delamanid is one of the first new TB medicines in over 50 years, and recently the project team in Dushanbe, Tajikistan's capital, started treating a young TB patient with it. It follows several months of preparations and negotiations with the Ministry of Health and its counterparts.

Read More →

India: New drugs, new hope

Two new drugs, bedaquiline and delamanid, are proving to be the very last life-line for TB patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able to access them as they are not widely available.

Read More →

MSF reports on use of the new TB drugs bedaquiline and delamanid

Access to the new TB drugs remains severely limited worldwide, but MSF hopes its experience can inform and encourage wider use, while needed clinical research continue.

Read More →

How one organisation is helping Indians with extremely drug-resistant TB get the help they need

An article published in the Better India describes what Médecins Sans Frontières does for patients with extremely drug-resistant TB in India. The article is about one of those patients in Mumbai. Click here to read it and watch a short video.

Read More →

MSF general statement at the 56th Series of WIPO Assembly

Médecins Sans Frontières (MSF) would like to urge WIPO and its member states to tackle the on-going challenges of spiralling drug prices and neglect of public health priorities in the IP-driven medical innovation system.

Read More →

As U.N. General Assembly starts, MSF urges governments to set medical research policies that align with people’s health needs

New MSF report exposes pharma industry failings and highlights new ways of researching and developing medicines that address public health needs.

Read More →

MSF calls on G7 leaders to urgently address the critical gaps in global response to public health emergencies and unite to lower the price of live-saving medicines

Ise-Shima, Japan/Geneva May 26, 2016 - Two years since the first signs of the West Africa Ebola outbreak, the world today is little more prepared to respond to such an emergency than it was then, warns international humanitarian aid organisation Médecins Sans Frontières (MSF), while the lack of R&D into needed medicines and exorbitant medicine prices requires urgent and united action from the world leaders gathered in Japan.

Read More →

Lives on the Edge: Time to align medical research and development with people’s health needs

Médecins Sans Frontières (MSF) released a report that outlines shortcomings of the current system for new drug development. The report highlights resulting access barriers and proposes policy solutions.

Read More →

Page 2 of 4 · Total posts: 10

←First 1 2 3 Last→